1. Duncia, J.V., Chiu, A.T., Carini, D.J., Gregory, G.B., Johnson, A.L., Price, W.A., Wells, G.J., Wong, P.C., Calabrese, J.C., Timmermans, P.B. The discovery of potent nonpeptide angiotensin 11 receptor antagonists: a new class of potent antihypertensives. J. Med. Chem. 33, 1312–1329, 1990
2. Chiu, A.T., McCall, D.E., Price, W.A., Wong, P.C., Carini, D.J., Duncia, J.V., Wexler, R.R., Yoo, S.E., Johnson, A.L., Timmermans, P.B. Nonpeptide angiotensin 11 receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 252, 711–718, 1990
3. Blankley, C.J., Hodges, J.C., Klutchko, S.R., Himmelsbach, R.J., Chucholowski, A., Connolly, C.J., Neergaard, S.J., Van Nieuwenhze, M.S., Sebastian, A., Quin, J. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J. Med. Chem. 34, 3248–3260, 1991
4. DeGasparo, M., Husain, A., Alexander, W., Catt, K.J., Chiu, A.T., Drew, M., Goodfriend, T., Harding, J.W., Inagami, T., Timmermans, P.B.M.W.M. Proposed update of angiotensin receptor nomenclature. Hypertension. 25, 924–927X, 1995
5. Sandberg, K. Structural analysis and regulation of angiotensin II receptors. TEM. 5, 28–35, 1994